In syngeneic mice, NKG2DL-transduced tumor cells could be rapidly rejected and failed to develop into detectable tumors [11], and mice deficient in NKG2D exhibited a higher incidence or greater severity of tumors [12]. This evidence concerns the gene KLRK1 and neoplasm.